CDKN1B and breast cancer: APP knockdown (APP-kd) in breast cancer cells reduced cell growth via p27kip1 induction, promoting apoptosis, increasing sensitivity to therapeutic treatments, and delayed cell migration and invasion ability upon stimulation.